Drugs / Intravenous Immune Globulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01350440 | Aug 2011 → Jul 2013 | cerebellar ataxia | University of South Florida | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intravenous Immune Globulin | “Intravenous Immune Globulin” NCT01350440 ↗ |
| Known as | IVIG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01350440 ↗ |
| Modality | Protein / enzyme biologic | “Intravenous Immune Globulin” NCT01350440 ↗ |
| Route | Intravenous | “Intravenous Immune Globulin” NCT01350440 ↗ |